CULLINAN THERAPEUTICS INC (CGEM) Stock Balance Sheet
NASDAQ:CGEM - Nasdaq - US2300311063 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 76.66M | 83.00M | 98.43M | 156.20M | 59.80M | |||
| Marketable Securities | 227.17M | 315.97M | 368.63M | 311.10M | 230.70M | |||
| Other Current Assets | 13.95M | 15.69M | 13.12M | 7.20M | 6.10M | |||
| Total Current Assets | 317.77M | 414.67M | 480.19M | 474.50M | 296.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.16M | 2.35M | 3.53M | 5.30M | 100.00K | |||
| Investments And Advances | 259.39M | 204.44M | 0.00 | 80.90M | 140.40M | |||
| Other Non-Current Assets | 366.00K | 366.00K | 459.00K | 500.00K | 100.00K | |||
| Total Non-Current Assets | 261.91M | 207.16M | 3.99M | 86.60M | 140.60M | |||
| TOTAL ASSETS | 579.68M | 621.82M | 484.18M | 561.10M | 437.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 200.00K | 0.00 | |||
| Accrued Expenses | 21.15M | 28.96M | 25.64M | 15.40M | 8.60M | |||
| Accounts Payable | 3.40M | 1.68M | 2.49M | 2.70M | 3.20M | |||
| Other Current Liabilities | 2.79M | N/A | 0.00 | 4.30M | N/A | |||
| Total Current Liabilities | 27.35M | 30.65M | 28.14M | 22.50M | 11.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 493.00K | 849.00K | 2.15M | 3.60M | 100.00K | |||
| Total Non-Current Liabilities | 493.00K | 849.00K | 2.34M | 3.60M | 500.00K | |||
| TOTAL LIABILITIES | 27.84M | 31.50M | 30.48M | 26.10M | 12.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -416.74M | -368.24M | -200.86M | -47.70M | -158.90M | |||
| Additional Paid In Capital | 968.07M | 958.70M | 654.68M | 585.30M | 584.70M | |||
| Minority Interest | 0.00 | 0.00 | 192.00K | 0.00 | 400.00K | |||
| Common Shares | 6.00K | 6.00K | 4.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 505.00K | -133.00K | -129.00K | -2.60M | -800.00K | |||
| Shares Outstanding | 58.70M | 58.51M | 42.90M | 45.80M | 44.30M | |||
| Tangible Book Value per Share | 9.40 | 10.09 | 10.58 | 11.68 | 9.59 | |||
| Total Shareholders' Equity | 551.84M | 590.33M | 453.70M | 535.00M | 425.00M | |||
| TOTAL LIABILITIES AND EQUITY | 579.68M | 621.82M | 484.18M | 561.10M | 437.20M | |||
| Statistics | ||||||||
| Current Ratio | 11.62 | 13.53 | 17.07 | 21.09 | 25.35 | |||
| Return On Assets (ROA) | -30.83% | -26.92% | -31.63% | 19.82% | -15.00% | |||
| Return On Equity (ROE) | -32.39% | -28.35% | -33.76% | 20.79% | -15.43% | |||
All data in USD , ROIC based on taxRate of 0.21